An objective of the Pipeline initiative is to facilitate and encourage access by fee-paying third parties to Pipeline member capabilities. To do this, TIA has developed a voucher-style researcher access scheme - the Pipeline Accelerator.
This scheme provides access to support funding to SMEs and research groups for meritorious projects, identified through an open call, with the intention of supporting that project’s access to at least one facility associated with TIA.
Funding, via a fixed-value reimbursement to the service provider, is intended to further reduce the cost of access to a specific capability. Projects are assessed by a panel including external experts on the basis of their scientific quality and potential for development of a therapeutic product.
This round of the Pipeline Accelerator scheme seeks to support meritorious therapeutic development projects that specifically relate to drug discovery through screening of small molecule libraries against drug targets. This includes pre-screening assay development and/or hit validation post-screening. A group of eligible screening facilities has been selected for this round.
Download the scheme's guidelines and documentation to the right.
This round of the scheme is now closed. Check back in early 2020 for information on the next round.